Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02752256 · ClinicalTrials.gov registry record
Thrombolytic Care During Inter-hospital Transfer
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 76
- Enrollment target
NCT02752256 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 76 participants.
The verdict
NCT02752256 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
Interventions
- DRUG Tissue Plasminogen Activator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02752256
The ClinicalTrials.gov registry entry for NCT02752256 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tissue Plasminogen Activator is the first listed.
NCT02752256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02752256 about?
NCT02752256 is a clinical study titled "Thrombolytic Care During Inter-hospital Transfer". Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
What is the current status of trial NCT02752256?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2015-10. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02752256?
The interventions under investigation include: Tissue Plasminogen Activator (DRUG).
Who is sponsoring clinical trial NCT02752256?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.